Horizon Therapeutics Public Ltd Co

AQR CAPITAL MANAGEMENT LLC

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/14/2023

Shares

109,883

Value ($000)

12,712

Weight

0.0%

2019 Q4 - 2023 Q3 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/14/2023	12,712	0.0%	109,883	9/30/2023
2023 Q2	8/14/2023	11,431	0.0%	111,144	6/30/2023
2023 Q1	5/15/2023	12,901	0.0%	118,202	3/31/2023
2022 Q4	2/14/2023	33,034	0.1%	290,795	12/31/2022
2022 Q3	11/14/2022	36,169	0.1%	584,407	9/30/2022
2022 Q2	8/15/2022	21,965	0.0%	275,390	6/30/2022
2022 Q1	5/16/2022	20,836	0.0%	198,046	3/31/2022
2021 Q4	2/14/2022	19,592	0.0%	181,808	12/31/2021
2021 Q3	11/15/2021	14,416	0.0%	131,607	9/30/2021
2021 Q2	8/16/2021	16,194	0.0%	172,938	6/30/2021
2021 Q1	5/17/2021	15,923	0.0%	175,980	3/31/2021
2020 Q4	2/16/2021	21,127	0.0%	294,254	12/31/2020
2020 Q3	11/16/2020	30,594	0.1%	393,846	9/30/2020
2020 Q2	8/17/2020	58,933	0.1%	1,072,476	6/30/2020
2020 Q1	5/15/2020	31,286	0.1%	1,056,231	3/31/2020
2019 Q4	2/14/2020	26,573	0.0%	734,072	12/31/2019